Literature DB >> 11294944

CSF tau and Abeta42 levels in patients with Down's syndrome.

T Tapiola1, H Soininen, T Pirttilä.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11294944     DOI: 10.1212/wnl.56.7.979

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  17 in total

1.  Diet intervention and cerebrospinal fluid biomarkers in amnestic mild cognitive impairment.

Authors:  Jennifer L Bayer-Carter; Pattie S Green; Thomas J Montine; Brian VanFossen; Laura D Baker; G Stennis Watson; Laura M Bonner; Maureen Callaghan; James B Leverenz; Brooke K Walter; Elaine Tsai; Stephen R Plymate; Nadia Postupna; Charles W Wilkinson; Jing Zhang; Johanna Lampe; Steven E Kahn; Suzanne Craft
Journal:  Arch Neurol       Date:  2011-06

2.  The AT(N) framework for Alzheimer's disease in adults with Down syndrome.

Authors:  Michael S Rafii; Beau M Ances; Nicole Schupf; Sharon J Krinsky-McHale; Mark Mapstone; Wayne Silverman; Ira Lott; William Klunk; Elizabeth Head; Brad Christian; Florence Lai; H Diana Rosas; Shahid Zaman; Melissa E Petersen; Andre Strydom; Juan Fortea; Benjamin Handen; Sid O'Bryant
Journal:  Alzheimers Dement (Amst)       Date:  2020-10-27

3.  Bilirubin as a determinant for altered neurogenesis, neuritogenesis, and synaptogenesis.

Authors:  Adelaide Fernandes; Ana Sofia Falcão; Elsa Abranches; Evguenia Bekman; Domingos Henrique; Lorene M Lanier; Dora Brites
Journal:  Dev Neurobiol       Date:  2009-08       Impact factor: 3.964

Review 4.  Aging in Down Syndrome and the Development of Alzheimer's Disease Neuropathology.

Authors:  Elizabeth Head; Ira T Lott; Donna M Wilcock; Cynthia A Lemere
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

5.  [Hereditary Alzheimer's disease with amyloid angiopathy caused by amyloid precursor protein locus].

Authors:  H Axer; S Hüge; C Wilhelm; M Axer; A Kunze; J R Reichenbach; M Freesmeyer; J Kohlhase; H Sauer; K-J Bär
Journal:  Nervenarzt       Date:  2009-01       Impact factor: 1.214

6.  Altered cerebrospinal fluid levels of amyloid β and amyloid precursor-like protein 1 peptides in Down's syndrome.

Authors:  Erik Portelius; Mikko Hölttä; Hilkka Soininen; Maria Bjerke; Henrik Zetterberg; Anni Westerlund; Sanna-Kaisa Herukka; Kaj Blennow; Niklas Mattsson
Journal:  Neuromolecular Med       Date:  2014-04-18       Impact factor: 3.843

7.  Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's disease.

Authors:  Anne M Fagan; Chengjie Xiong; Mateusz S Jasielec; Randall J Bateman; Alison M Goate; Tammie L S Benzinger; Bernardino Ghetti; Ralph N Martins; Colin L Masters; Richard Mayeux; John M Ringman; Martin N Rossor; Stephen Salloway; Peter R Schofield; Reisa A Sperling; Daniel Marcus; Nigel J Cairns; Virginia D Buckles; Jack H Ladenson; John C Morris; David M Holtzman
Journal:  Sci Transl Med       Date:  2014-03-05       Impact factor: 17.956

Review 8.  Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.

Authors:  Piotr Lewczuk; Peter Riederer; Sid E O'Bryant; Marcel M Verbeek; Bruno Dubois; Pieter Jelle Visser; Kurt A Jellinger; Sebastiaan Engelborghs; Alfredo Ramirez; Lucilla Parnetti; Clifford R Jack; Charlotte E Teunissen; Harald Hampel; Alberto Lleó; Frank Jessen; Lidia Glodzik; Mony J de Leon; Anne M Fagan; José Luis Molinuevo; Willemijn J Jansen; Bengt Winblad; Leslie M Shaw; Ulf Andreasson; Markus Otto; Brit Mollenhauer; Jens Wiltfang; Martin R Turner; Inga Zerr; Ron Handels; Alexander G Thompson; Gunilla Johansson; Natalia Ermann; John Q Trojanowski; Ilker Karaca; Holger Wagner; Patrick Oeckl; Linda van Waalwijk van Doorn; Maria Bjerke; Dimitrios Kapogiannis; H Bea Kuiperij; Lucia Farotti; Yi Li; Brian A Gordon; Stéphane Epelbaum; Stephanie J B Vos; Catharina J M Klijn; William E Van Nostrand; Carolina Minguillon; Matthias Schmitz; Carla Gallo; Andrea Lopez Mato; Florence Thibaut; Simone Lista; Daniel Alcolea; Henrik Zetterberg; Kaj Blennow; Johannes Kornhuber
Journal:  World J Biol Psychiatry       Date:  2017-10-27       Impact factor: 4.132

9.  Blood-based biomarkers for Down syndrome and Alzheimer's disease: A systematic review.

Authors:  Melissa E Petersen; Sid E O'Bryant
Journal:  Dev Neurobiol       Date:  2019-09-03       Impact factor: 3.964

Review 10.  Clinical aspects and biomarkers of Alzheimer's disease in Down syndrome.

Authors:  Panagiotis Zis; Andre Strydom
Journal:  Free Radic Biol Med       Date:  2017-09-01       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.